Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
about
Velnacrine for Alzheimer's diseaseCholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.North of England evidence based guidelines development project: guideline for the primary care management of dementiaNeurotransmitter replacement therapy in Alzheimer's disease.Cholinesterase inhibitors for behavioral disturbance in dementia.Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014Velnacrine maleate improves delayed matching performance by aged monkeys.
P2860
Q24247210-FCEC9EC1-B0F0-4852-AF45-010DE26D3CC6Q33637687-22041C97-3471-4B16-8327-0DD54A71306AQ33791951-DCF9B56E-16CA-45E7-88D3-EAD9EC3F16AAQ33921314-0AA87370-2C12-4357-A5E0-82E4EA117899Q34251448-20EE7F3D-3B86-492D-8B95-5079E47968D8Q34408888-8A76DC62-FB50-47D6-8220-83A55830A7F3Q52053059-BF3BE11D-2138-4D97-976B-105F46A650F9
P2860
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
@ast
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
@en
type
label
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
@ast
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
@en
prefLabel
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
@ast
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
@en
P2093
P2860
P1476
Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease.
@en
P2093
Demkovich JJ
Hardiman ST
P2860
P304
P356
10.1111/J.1749-6632.1991.TB00229.X
P407
P577
1991-01-01T00:00:00Z